XWRAP® is a regenerative, anti-adhesive, anti-inflammatory, and anti-microbial amnion derived biological used to repair DFUs, VLUs,
and Pressure Ulcers.
XWRAP® is intended for, but not limited to use for chronic wound repair.
XWRAP® is the intermediate amniotic epithelial layer of the placenta. This layer is a rich source of epidermal growth factor (EGF), fibroblast
growth factor (FGF), platelet derived growth factor (PDGF), and vascular endothelial growth factor (VEGF), which stimulate angiogenesis; Tissue
inhibitors of metalloproteinases (TIMPs), which inhibit metalloproteinase activity and matrix degradation; Extracellular matrix proteins such as
fibronectins and laminins, which drive cell attachment, migration, and subsequent organization; as well as Type I, II, III, V, and VI collagen.
XWRAP® is recovered during a Cesarean delivery from healthy, pre-screened donors, and is processed to preserve the structural integrity of the
amniotic epithelial membrane. A Clinical Laboratory Improvement Amendment (CLIA) certified lab that meets or exceeds the American Association
of Tissue Banks (AATB) criteria screens and tests XWRAP® to minimize the risk of communicable diseases. All donors’ medical history and behavior
is assessed and evaluated following United States Public Health Service (USPHS) guidelines.
XWRAP® is an allograft tissue that is regulated under section 361 of the PHS Act and meets the criteria of Title 21 Code for Federal Regulation
(CFR) 1271.3 and 1271.10. From tissue recovery, tissue processing, and packaging, Applied Biologics ensures that each unit of XWRAP® has
been carefully screened and meets industry standards for the use of biologic products in surgery.
Return Policy
Items are sold as-is with no returns or refunds available unless explicitly stated.